查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2018958

医用黏合剂市场：按产品类型、原料、应用和最终用户划分－2026-2032年全球市场预测

Medical Adhesives Market by Product Type, Raw Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用黏合剂市场价值将达到 120.5 亿美元，到 2026 年将成长至 130.3 亿美元，到 2032 年将达到 208.7 亿美元，复合年增长率为 8.15%。

主要市场统计数据
基准年 2025 120.5亿美元
预计年份：2026年 130.3亿美元
预测年份 2032 208.7亿美元
复合年增长率 (%) 8.15%

对医用黏合剂市场进行策略性介绍，重点在于临床需求、材料进步、製造技术发展和监管趋势。

本执行摘要首先清楚概述了现代医用黏合剂市场，并说明了影响产品开发、临床应用和供应链趋势的根本因素。文章重点阐述了材料科学的进步、不断发展的临床方案以及日益严格的过程如何使黏合剂从普通商品组件跃升为患者照护过程中不可或缺的要素。

对医用黏合剂的关键变革进行深入分析，重点关注数位化製造、新型化学技术、永续发展趋势和临床整合。

在这个领域，一系列变革正在发生，这些变革超越了简单的产品改进，重新定义了黏合剂的设计、规格製定和采购流程。在材料方面，配方研发人员正转向研发兼顾黏合性能、生物相容性和易去除性的化学成分，并将临床医生的回馈和患者的舒适度放在首位。同时，生产流程也日益数位化，从而提高了生产效率，加强了流程控制，并实现了更稳定的品质结果——所有这些特性对于无菌一次性应用至关重要。

对 2025 年美国关税对医用黏合剂。

美国于2025年实施的关税政策对整个医用黏合剂链上的相关人员的采购和成本结构产生了重大影响。供应商和买家被迫重新评估其供应商多元化、物流规划和库存策略，以降低到货成本上升和运输成本波动带来的风险。这些调整促使各方更加重视尽可能进行在地化生产，并采用合约机制来分担买卖双方之间的关税风险。

透过细分市场洞察，揭示产品类型、原材料、应用和最终用户趋势如何推动创新、临床应用和采购选择。

市场区隔提供了一个实用的观点，帮助我们理解产品、材料、应用和最终用户等维度上的性能、监管负担和商业性机会之间的相互影响。基于产品类型，我们将市场分为黏合剂、液体黏合剂、压敏黏着剂和反应型黏合剂。这种分类突显了配方优先顺序的差异，例如是否需要耐热处理性能，或优先考虑低温性能或长期黏合稳定性。基于原料，我们根据化学成分（例如丙烯酸酯、橡胶和硅酮）分析市场。这种分类突显了黏性、生物相容性和基材通用性之间的权衡。

透过对美洲、欧洲、中东和非洲以及亚太地区的比较，区域洞察揭示了需求推动要素、监管环境和供应韧性。

区域趋势对全球医用黏合剂市场的产品规格、监管策略和供应商参与度有显着影响。在美洲，买家优先考虑产品上市速度、可靠的上市后监控数据和供应稳定性，促使供应商优先考虑快速的物流反应和完善的品管系统。在欧洲、中东和非洲，监管协调统一的压力正在影响对应用文件的期望，而成本敏感性和基于价值的采购模式则影响着与供应商就总体拥有成本进行的讨论。在亚太地区，快速扩大生产规模的能力和不断完善的临床基础设施为本地创新以及能够证明其合规性和具有竞争力的生产成本的供应商创造了机会。

公司层面的关键亮点包括研发重点、併购活动、製造地优化以及与临床合作伙伴的合作模式。

该产业的企业发展趋势反映了两大关键优先事项：技术差异化和营运稳健性。主要企业正集中研发能够提高生物相容性、增强对敏感皮肤的可预测黏附性以及与监测电子设备相容性的化学技术。同时，企业正透过有针对性的伙伴关係、产能扩张和选择性併购等策略措施，确保原料供应管道畅通、缩短新配方上市时间并提升合规性。

为产业领导者提供加速创新、增强供应链韧性、优化采购和提高合规性的实用建议。

产业领导者应优先考虑一系列切实可行的倡议，将策略意图转化为实际营运成果。首先，应加速推进针对关键临床挑战的创新项目，而非进行大范围、无差别的配方变更。其次，应透过多元化认证供应商、探索近岸生产能力以及在商业合约中纳入关税和物流应急计画，以增强价值链的韧性。这些措施将在不牺牲产品品质的前提下，降低风险敞口，提升谈判优势。

一种高度透明的调查方法，概述了支持调查结果的数据收集、一级和二级调查、检验过程和分析方法。

本执行摘要所依据的研究透过结合与关键相关人员的初步定性研究和严谨的二手资讯整合，确保了研究的深度和检验。初步研究包括对临床使用者、采购经理、研发科学家和生产合作伙伴进行结构化访谈，以获取关于绩效预期、采购槓桿和推广障碍的第一手观点。访谈结果透过有针对性的后续跟进进行交叉检验，以确认关键假设并识别不同终端使用者群体之间的差异。

对创新、监管、采购和临床部署等方面的策略见解进行简洁整合，并为相关人员。

总之，本报告整合了医疗黏合剂产业企业最重要的洞见，并以清晰简洁的方式总结了策略重点。材料和製造技术的进步为满足尚未满足的临床需求创造了机会，但要抓住这些机会，还需要同时投资于监管准备、临床检验和供应链稳健性。能够使产品性能与临床医生工作流程和患者舒适度相匹配的企业更有可能实现可持续的市场推广。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医用黏合剂市场：依产品类型划分

  • 黏合剂
  • 液体黏合剂
  • 压敏黏着剂
  • 反应型黏合剂

第九章 医用黏合剂市场：依原料划分

  • 丙烯酸纤维
  • 橡胶基
  • 硅基

第十章 医用黏合剂市场：依应用领域划分

  • 诊断
  • 固定电极
  • 整形外科固定
  • 伤口缝合

第十一章 医用黏合剂市场：依最终用户划分

  • 诊所
  • 居家照护
  • 医院

第十二章 医用黏合剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 医用黏合剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 医用黏合剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国医用黏合剂市场

第十六章：中国医用黏合剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Advanced Medical Solutions Group PLC
  • Avery Dennison Corporation
  • B. Braun Melsungen AG
  • Berry Global Group, Inc.
  • Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • GluStitch Inc.
  • HB Fuller Company
  • Henkel AG & Co. KGaA
  • Johnson & Johnson Services, Inc.
  • Lohmann GmbH & Co. KG
  • Medtronic PLC
  • Nitto Denko Corporation
  • Panacol-Elosol GmbH
  • Permabond LLC
  • Scapa Group plc
  • Sika AG
  • TELA Bio, Inc.
  • The Dow Chemical Company
  • Urocare Products, Inc.
Product Code: MRR-EC2E133E327A

The Medical Adhesives Market was valued at USD 12.05 billion in 2025 and is projected to grow to USD 13.03 billion in 2026, with a CAGR of 8.15%, reaching USD 20.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.05 billion
Estimated Year [2026] USD 13.03 billion
Forecast Year [2032] USD 20.87 billion
CAGR (%) 8.15%

A strategic introduction to the medical adhesives landscape highlighting clinical demands, material evolution, manufacturing advances, and regulatory dynamics

This executive summary opens with a clear orientation to the modern medical adhesives landscape, describing the underlying forces that are shaping product development, clinical adoption, and supply chain behavior. The narrative emphasizes how advances in materials science, coupled with shifting clinical protocols and heightened regulatory scrutiny, have combined to elevate adhesives from commodity components to critical enablers of patient care pathways.

The introduction situates recent innovations-such as more biocompatible chemistries and manufacturing process improvements-against operational realities including sterilization compatibility and packaging integrity. It also contextualizes the role of adhesives within broader clinical device ecosystems where adhesion performance impacts wound healing, electrode stability, and immobilization in orthopedic procedures. By framing these dynamics up front, the introduction sets expectations for subsequent sections that explore technological inflection points, regional nuances, tariff implications, and segment-specific behaviors. The tone is strategic and pragmatic, intended for executives, product leads, and procurement managers who require both a panoramic view and direct linkages to decision-focused implications.

An incisive exploration of major shifts in medical adhesives, focusing on digital fabrication, novel chemistries, sustainability trends, and clinical integration

The sector is experiencing a cluster of transformative shifts that extend beyond incremental product improvements to redefine how adhesives are designed, specified, and procured. On the materials front, formulators are migrating toward chemistries that balance adhesion performance with cytocompatibility and ease of removal, driven by clinician feedback and patient comfort priorities. At the same time, manufacturing is becoming increasingly digitized, enabling higher throughput, tighter process control, and more consistent quality outcomes-attributes that matter for sterile, single-use applications.

Sustainability considerations are also influencing raw material selection and packaging design, with procurement teams requiring clearer life-cycle narratives from suppliers. Clinically, there is heightened demand for adhesives that integrate with monitoring systems, maintain signal integrity for electrodes, and support minimally invasive orthopedic stabilization. Regulatory expectations continue to tighten, prompting manufacturers to invest in more robust documentation and testing pathways. Collectively, these shifts are prompting cross-functional alignment among R&D, quality, and commercial teams, and are reshaping the supplier landscape toward partners who can demonstrate both technical depth and operational reliability.

A focused assessment of how United States tariffs in 2025 influenced medical adhesives supply chains, procurement behavior, sourcing, and cost dynamics

The imposition of United States tariffs in 2025 has had a material effect on how stakeholders approach sourcing and cost structures across the medical adhesives value chain. Suppliers and purchasers have had to reassess supplier diversification, logistics planning, and inventory policies in order to mitigate exposure to increased landed costs and transit volatility. These adjustments have led to renewed emphasis on localized manufacturing footprints where feasible, and on contractual mechanisms that share tariff risk between buyers and sellers.

Procurement teams have also accelerated conversations around formulation standardization to reduce part complexity and to increase leverage with qualified suppliers. Clinical teams, in turn, are sensitive to any potential disruptions that might affect product availability, and are collaborating more closely with supply chain leaders to define acceptable cross-qualified alternatives. From a commercialization standpoint, organizations are prioritizing transparency in cost build-ups and are exploring hedging and longer-term supplier commitments to preserve continuity of care. While tariffs have introduced near-term complexity, they have also catalyzed more rigorous supplier qualification and contingency planning across the ecosystem.

Segmentation insights illuminating how product type, raw material, application, and end-user dynamics drive innovation, clinical uptake, and procurement choices

Segmentation provides a practical lens for understanding where performance, regulatory burden, and commercial opportunity intersect across product, material, application, and end-user dimensions. Based on Product Type, market is studied across Hot Melt Adhesive, Liquid Adhesive, Pressure Sensitive Adhesive, and Reactive Adhesive, and this classification highlights divergent formulation priorities where some types demand thermal processing robustness while others prioritize low-temperature performance or long-term bonding stability. Based on Raw Material, market is studied across Acrylic Based, Rubber Based, and Silicone Based chemistries, a distinction that underscores trade-offs between tack, biocompatibility, and substrate versatility.

Based on Application, market is studied across Diagnostics, Electrode Fixation, Orthopedic Fixation, and Wound Closure, which illuminates how adhesion requirements are driven by use-case specifics such as signal fidelity for diagnostics or secure fixation under biomechanical load for orthopedic uses. Based on End User, market is studied across Clinics, Home Care, and Hospitals, revealing variation in procurement cycles, sterilization expectations, and user training demands. Together, these segmentation perspectives illuminate where development investments should concentrate, how regulatory strategies must be tailored, and which commercial channels warrant prioritized engagement to accelerate acceptance and scale.

Regional insights comparing Americas, Europe Middle East & Africa, and Asia-Pacific to reveal demand drivers, regulatory landscapes, and supply resilience

Regional dynamics materially influence product specification, regulatory strategy, and supplier engagement across the global medical adhesives landscape. In the Americas, buyers emphasize speed to market, strong post-market surveillance data, and supply continuity, prompting suppliers to prioritize responsive logistics and robust quality systems. In Europe, Middle East & Africa, regulatory alignment and harmonization pressures are shaping dossier expectations, while cost-sensitivity and value-based procurement models influence supplier discussions on total cost of ownership. In the Asia-Pacific region, rapid manufacturing scale-up capabilities and expanding clinical infrastructure are creating opportunities for localized innovation and for suppliers that can demonstrate both compliance and competitive production economics.

These regional contrasts have operational implications: design-for-manufacturability choices must consider regulatory submission pathways and sterilization standards that vary by jurisdiction, and commercialization strategies need to reflect channel structures that differ significantly between hospital systems, clinic networks, and home care distribution. Moreover, geopolitical developments and logistics constraints can alter supplier selection criteria, making it essential for companies to embed regional scenario planning into product roadmap and supply chain strategies to preserve resilience and to maximize access across diverse healthcare markets.

Key company-level insights highlighting R&D focus, M&A activity, manufacturing footprint optimization, and collaborative models with clinical partners

Company behavior in this sector demonstrates a dual focus on technological differentiation and operational robustness. Leading manufacturers are concentrating R&D efforts on chemistries that deliver enhanced biocompatibility, predictable adhesion for sensitive skin, and compatibility with monitoring electronics. At the same time, strategic moves such as targeted partnerships, capacity expansions, and selective M&A are being used to secure raw material pipelines, accelerate time-to-market for new formulations, and broaden regulatory footprints.

There is also a clear trend toward collaborative models that bring suppliers, clinicians, and contract manufacturers into earlier-stage co-development discussions. This shift reduces iteration cycles and increases the likelihood of clinical acceptance by aligning performance attributes with real-world workflows. For companies evaluating their competitive posture, the emphasis is on demonstrating validated performance under clinically relevant conditions, investing in regulatory readiness, and ensuring manufacturing scalability. Those that can couple compelling technical differentiation with supply chain transparency and certification are better positioned to win long-term institutional contracts and to support home care and clinic-level adoption.

Practical recommendations for industry leaders to accelerate innovation, reinforce supply chain resilience, optimize procurement, and improve regulatory alignment

Industry leaders should prioritize a set of pragmatic actions that translate strategic intent into operational outcomes. First, accelerate targeted innovation projects that solve high-value clinical pain points rather than pursuing broad, undifferentiated formulation changes. Second, strengthen supply chain resilience by diversifying qualified suppliers, assessing near-shore capacity options, and embedding tariff and logistics contingencies into commercial agreements. These steps reduce exposure and increase negotiating leverage without sacrificing quality.

Third, align regulatory strategies with clinical evidence generation by designing validation programs that reflect end-user conditions and by investing in post-market surveillance to substantiate safety and performance claims. Fourth, optimize procurement engagement by offering multi-tiered product portfolios that accommodate both institutional tenders and the growing home care channel. Finally, cultivate closer collaboration between R&D, quality, and commercialization teams to shorten time-to-adoption and to ensure that launch packs, training materials, and technical support address real-world use. Taken together, these recommendations help organizations balance short-term continuity with long-term differentiation.

Transparent methodology outlining data collection, primary and secondary research, validation processes, and analytical techniques that underpin findings

The research underpinning this executive summary combines primary qualitative engagement with key stakeholders and rigorous secondary-source synthesis to ensure both depth and triangulation. Primary work included structured interviews with clinical users, procurement leaders, R&D scientists, and manufacturing partners to capture first-hand perspectives on performance expectations, procurement levers, and adoption barriers. Interview findings were cross-validated through targeted follow-ups to confirm critical assumptions and to map divergence across end-user segments.

Secondary research comprised an analysis of regulatory guidance, technical standards, patent activity, and published clinical literature to contextualize formulation trends and to identify validated performance measures. Validation frameworks were applied to reconcile divergent inputs, test hypotheses about supply chain behavior, and confirm the applicability of recommended actions across regions and end-user settings. Analytical techniques included qualitative thematic coding and comparative scenario analysis to translate signals from interviews and documents into actionable implications. The methodology emphasizes transparency, reproducibility, and practical orientation so that findings can be applied directly to business planning and product development choices.

Concise synthesis of strategic implications across innovation, regulation, sourcing, and clinical adoption, setting actionable next steps for stakeholders

The conclusion synthesizes the most consequential implications for organizations operating in the medical adhesives space and offers a crisp summary of strategic priorities. Technological progress in materials and manufacturing is creating opportunities to address unmet clinical needs, but realizing that potential requires concurrent investments in regulatory preparation, clinical validation, and supply chain robustness. Companies that align product performance with clinician workflows and patient comfort are more likely to achieve durable adoption.

Regional nuances and tariff developments underscore the need for flexible sourcing strategies and for scenario-based planning. Segmentation-aware product roadmaps, where formulations are tailored to specific applications and end-user requirements, will outperform one-size-fits-all approaches. Finally, organizational alignment across R&D, quality, and commercial functions is a critical enabler of speed and consistency during product launches. Embracing these priorities positions companies to convert technical capability into operational advantage and to support safer, more reliable clinical outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Adhesives Market, by Product Type

  • 8.1. Hot Melt Adhesive
  • 8.2. Liquid Adhesive
  • 8.3. Pressure Sensitive Adhesive
  • 8.4. Reactive Adhesive

9. Medical Adhesives Market, by Raw Material

  • 9.1. Acrylic Based
  • 9.2. Rubber Based
  • 9.3. Silicone Based

10. Medical Adhesives Market, by Application

  • 10.1. Diagnostics
  • 10.2. Electrode Fixation
  • 10.3. Orthopedic Fixation
  • 10.4. Wound Closure

11. Medical Adhesives Market, by End User

  • 11.1. Clinics
  • 11.2. Home Care
  • 11.3. Hospitals

12. Medical Adhesives Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Adhesives Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Adhesives Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Adhesives Market

16. China Medical Adhesives Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Advanced Medical Solutions Group PLC
  • 17.7. Avery Dennison Corporation
  • 17.8. B. Braun Melsungen AG
  • 17.9. Berry Global Group, Inc.
  • 17.10. Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • 17.11. GluStitch Inc.
  • 17.12. H.B. Fuller Company
  • 17.13. Henkel AG & Co. KGaA
  • 17.14. Johnson & Johnson Services, Inc.
  • 17.15. Lohmann GmbH & Co. KG
  • 17.16. Medtronic PLC
  • 17.17. Nitto Denko Corporation
  • 17.18. Panacol-Elosol GmbH
  • 17.19. Permabond LLC
  • 17.20. Scapa Group plc
  • 17.21. Sika AG
  • 17.22. TELA Bio, Inc.
  • 17.23. The Dow Chemical Company
  • 17.24. Urocare Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL ADHESIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL ADHESIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOT MELT ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOT MELT ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOT MELT ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY LIQUID ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY LIQUID ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY LIQUID ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRESSURE SENSITIVE ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRESSURE SENSITIVE ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRESSURE SENSITIVE ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REACTIVE ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REACTIVE ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REACTIVE ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RUBBER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RUBBER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RUBBER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY SILICONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY SILICONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY SILICONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. GCC MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. GCC MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GCC MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. G7 MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. G7 MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. G7 MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NATO MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. NATO MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NATO MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)